Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/274
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,3-diazines (e.g., pyrimidines, etc.) > Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety > Chalcogen bonded directly to pyrimidine at 2-position
Description: Subject matter wherein a chalcogen is directly bonded to the 2-position of the pyrimidine.

Patents under this class:

Patent Number Title Of Patent Date Issued
8703759 Fused heterocyclic compounds as ion channel modulators Apr. 22, 2014
8703725 Nutritional compositions Apr. 22, 2014
8691878 Solid pharmaceutical dosage form Apr. 8, 2014
8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Apr. 8, 2014
8686007 Certain heterocycles, compositions thereof, and methods for their use Apr. 1, 2014
8685991 Anti-infective agents and uses thereof Apr. 1, 2014
8685974 Thienylpyri(mi)dinylazole Apr. 1, 2014
8673926 Spiro[2.4]heptanes for treatment of flaviviridae infections Mar. 18, 2014
8673910 Proteasome inhibitors for selectively inducing apoptosis in cancer cells Mar. 18, 2014
8669273 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine Mar. 11, 2014
8669246 Substituted amide compound Mar. 11, 2014
8658660 5-fluoro-4-imino-3,4-dihydropyrimidin-2-(1H)-ones derivatives Feb. 25, 2014
8658659 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors Feb. 25, 2014
8658618 Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs Feb. 25, 2014
8653002 Aqueous suspension concentrate formulations containing saflufenacil Feb. 18, 2014
8637536 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA.sub.2 Jan. 28, 2014
8637535 Polymorphic and other crystalline forms of cis-FTC Jan. 28, 2014
8637511 Aminopyrimidines useful as kinase inhibitors Jan. 28, 2014
8637509 Azaindazoles Jan. 28, 2014
8629102 3-hydroxyisothiazole 1-oxide derivatives Jan. 14, 2014
8609677 Molecules for the photodynamic treatment of tumors and hyperplasias Dec. 17, 2013
8598188 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer Dec. 3, 2013
8598175 Heteroarylamide pyrimidone derivatives Dec. 3, 2013
8592437 Heteroarylamide pyrimidone compounds Nov. 26, 2013
8586536 Neprilysin inhibitors Nov. 19, 2013
8580805 Pyrimidine carboxamide derivatives Nov. 12, 2013
8574563 Hepatitis C virus inhibitors Nov. 5, 2013
8569322 Lamivudine oxalate and preparation method thereof Oct. 29, 2013
8569321 Phosphonate ester derivatives and methods of synthesis thereof Oct. 29, 2013
8569320 Topical composition for the treatment of actinic keratosis Oct. 29, 2013
8569302 Inhibitors of flaviviridae viruses Oct. 29, 2013
8563565 Pyrazoloquinoline derivatives Oct. 22, 2013
8557834 Prolyl hydroxylase inhibitors Oct. 15, 2013
8557833 Aminopyrimidines useful as kinase inhibitors Oct. 15, 2013
8552021 Phosphoramidate derivatives of nucleosides Oct. 8, 2013
8552020 N1-substituted-5-fluoro-2-oxopyrimidinone-1(2H)-carboxamide derivatives Oct. 8, 2013
8551524 Anti-diabetic combinations Oct. 8, 2013
8546374 Amino-tetrazoles analogues and methods of use Oct. 1, 2013
8545897 Pyrrolopyridines as kinase inhibitors Oct. 1, 2013
8541433 Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer Sep. 24, 2013
8536198 Piperidine derivatives as modulators of chemokine receptor activity Sep. 17, 2013
8536188 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine Sep. 17, 2013
8530490 Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity Sep. 10, 2013
8530444 Pharmaceutical compounds Sep. 10, 2013
8524726 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors Sep. 3, 2013
8518916 Heterocyclic derivatives as M-GLU5 antagonists Aug. 27, 2013
8513252 Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors Aug. 20, 2013
8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Aug. 20, 2013
8501750 Heterocyclic compound and use thereof Aug. 6, 2013
8501242 Methods and compositions for treating neoplasia Aug. 6, 2013

  Recently Added Patents
Apparatus, method and program for image receipt, processing, conversion, and delivery to and from a plurality of external apparatuses
Image capture apparatus and program
Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human
Communication terminal, communication system, server apparatus, and communication connecting method
Vehicle driving assistance apparatus
Assisted hybrid mobile browser
Touch-sensitive device and communication device
  Randomly Featured Patents
Azepinoindole derivatives as pharmaceutical agents
Process for the simultaneous chemical and biological elimination of solid and liquid organic waste
Alkylated diphenyl ether lubricants
Scope adjustment method and apparatus
Poly(arylene ether) fractionation method
Multifocal contact lens and method and apparatus for making the same
Rate adaptation in a communication system
Method of measurement of number of nonmetallic inclusions and casting mold for obtaining cast sample used for same
Search and retrieval methods and systems of short messages utilizing messaging context and keyword frequency
Method and corresponding apparatus for quantitative measurements on sequences of images, particularly ultrasonic images